arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Abeona Therapeutics Inc.

ABEO Health Care Biotechnology: Pharmaceutical Preparations
$4.40
▼ -2.4% Today
as of Oct 23, 16:45 ET
Last 30 days -18.97% Sep 14 → Oct 23
$4.24 $4.67 $5.09 $5.51 $5.94 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.42
High
$4.43
Low
$4.29
Volume
$797,288
Avg Vol
$1M
Mkt Cap
$286M
P/E (TTM)
—
Beta
—
52w High
$7.65
52w Low
$4.00
Div Yield
—
Shares Out
$57M

Recent Press Releases & News last 60 days · 9 items

Oct 2 · 11:30 PR GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 22 · 22:02 MarketBeat
Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
Sep 22 · 08:02 MarketBeat
Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
▸ Show all 9 press releases & news Free account →

ABEO earnings at a glance

The options market is pricing a move of about ±12.1% after the report, a range of roughly $3.87 to $4.93 from today's $4.40. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±4.0% on average; after the most recent report on May 13, 2026 it moved +0.5%. That means options currently expect more movement than ABEO has typically delivered. ABEO beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 102%. The share price of $4.40 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$4.00
$7.65
11% of range
Avg surprise (last 4)
+160.5%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
102%
EM ±12.1% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.16$-0.44$0.28$0.99$1.71 Actual $-0.54Actual $-0.92Actual $-0.48Actual $-1.16Actual $-0.26Actual $-0.63Actual $-0.24Est $-0.35Actual $1.71Est $-0.39Actual $-0.10Est $-0.27Actual $-0.30Est $-0.33Actual $-0.35 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-30M$6M$42M$78M$114M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.35 — — — — financials
Wed May 13, 2026Mar/2026 $-0.30 $-0.33 +9.1% -25.0% +0.5% earnings
Wed Nov 12, 2025Sep/2025 $-0.10 $-0.27 +63.0% — — earnings
Thu Aug 14, 2025Jun/2025 $1.71 $-0.39 +538.5% — — earnings
Thu May 15, 2025Mar/2025 $-0.24 $-0.35 +31.4% — +7.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.63 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.16 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.48 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.92 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.54 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$11M$9M——$400,000———
Cost of revenue$4M$3M—$488,000————
Gross profit————————
Operating income$-14M$-23M—$-24M$-23M$-20M—$-15M
Net income$-20M$-17M—$-5M$109M$-12M—$-30M
EPS (diluted)$-0.35$-0.30—$-0.10$1.71$-0.24—$-0.63

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$56M$61M$78M$83M$164M$16M$23M$16M
Inventory$6M$6M$5M$5M$3M———
Total current assets$165M$183M$205M$216M$232M$88M$101M$113M
Total assets$180M$198M$220M$231M$246M$99M$109M$121M
Long-term debt$2M$5M$8M$11M$14M$11M$13M$14M
Total liabilities$51M$54M$60M$60M$83M$58M$65M$75M
Total equity$128M$145M$159M$171M$164M$41M$44M$46M

Implied volatility — last 90 days

29%416%802%1189%1576% Jun 07 — IV 132% · EM ±18.3%Jun 08 — IV 211% · EM ±27.9%Jun 09 — IV 218% · EM ±27.3%Jun 29 — IV 30% · EM ±5.3%Jul 07 — IV 578% · EM ±76.3%Jul 08 — IV 639% · EM ±80.0%Jul 09 — IV 196% · EM ±23.2%Jul 10 — IV 208% · EM ±22.9%Jul 20 — IV 84% · EM ±19.8%Jul 21 — IV 199% · EM ±46.2%Jul 22 — IV 131% · EM ±30.0%Jul 23 — IV 143% · EM ±32.1%Jul 24 — IV 155% · EM ±34.3%Jul 27 — IV 231% · EM ±48.3%Jul 28 — IV 162% · EM ±33.2%Jul 29 — IV 112% · EM ±22.5%Jul 31 — IV 403% · EM ±77.1%Aug 03 — IV 113% · EM ±20.0%Aug 04 — IV 116% · EM ±19.9%Aug 05 — IV 57% · EM ±9.6%Aug 07 — IV 93% · EM ±14.5%Aug 10 — IV 111% · EM ±15.4%Aug 11 — IV 169% · EM ±22.3%Aug 12 — IV 214% · EM ±26.8%Aug 13 — IV 389% · EM ±45.9%Aug 24 — IV 59% · EM ±12.4%Aug 25 — IV 60% · EM ±12.3%Aug 26 — IV 75% · EM ±15.0%Aug 27 — IV 38% · EM ±7.5%Aug 28 — IV 49% · EM ±9.3%Aug 31 — IV 58% · EM ±10.3%Sep 01 — IV 44% · EM ±7.5%Sep 02 — IV 45% · EM ±7.6%Sep 03 — IV 47% · EM ±7.6%Sep 04 — IV 37% · EM ±5.8%Sep 07 — IV 42% · EM ±5.8%Sep 08 — IV 65% · EM ±8.5%Sep 09 — IV 83% · EM ±10.4%Sep 11 — IV 201% · EM ±22.2%Sep 14 — IV 265% · EM ±22.1%Sep 15 — IV 1264% · EM ±91.4%Sep 16 — IV 1576% · EM ±93.1%Sep 17 — IV 343% · EM ±14.3%Sep 22 — IV 420% · EM ±85.9%Sep 23 — IV 32% · EM ±6.3%Sep 25 — IV 41% · EM ±7.9%Oct 01 — IV 61% · EM ±9.9%Oct 06 — IV 29% · EM ±3.9%Oct 08 — IV 102% · EM ±12.1%

Sector peers

INDP
Indaptus Therapeutics, Inc.
$282M $3.160.0%
PRLD
Prelude Therapeutics Incorporated
$302M $3.63-0.6%
BCYC
Bicycle Therapeutics plc
$261M $3.55-0.6%
AMRN
Amarin Corporation plc
$254M $11.79+2.4%
IFRX
InflaRx N.V.
$252M $1.56+0.7%
QTTB
Q32 Bio Inc.
$246M $8.65-0.2%

ABEO earnings FAQ

What is ABEO's expected move for earnings?

Options currently price a move of about ±12.1%, or $0.53 per share either way from $4.40.

How does ABEO stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.0%, up 2 times and down 0 times.

What is ABEO's implied volatility?

ABEO's at-the-money implied volatility is about 102% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in